Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)
Hong Kong · Delayed Price · Currency is HKD 13.10
0.00 (0.00%)
Aug 21, 2026, 3:11 PM HKT
HKG:2480 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 95.95 | 140.13 | 264.98 | 68.98 | 32.03 |
Trading Asset Securities | 323.52 | 313.55 | 343.35 | 512.66 | 532.37 |
Cash & Short-Term Investments | 419.46 | 453.68 | 608.33 | 581.64 | 564.4 |
Cash Growth | -7.54% | -25.42% | 4.59% | 3.06% | - |
Inventory | 3.65 | 5.74 | 3.48 | 2.54 | 5.32 |
Other Current Assets | 15.4 | 13.46 | 9.17 | 16.83 | 4.58 |
Total Current Assets | 438.51 | 472.88 | 620.97 | 601 | 574.29 |
Property, Plant & Equipment | 588.3 | 557.09 | 488.5 | 292.09 | 142.21 |
Long-Term Investments | 1 | - | - | - | - |
Other Intangible Assets | 8.19 | 8.33 | 4.13 | 3.44 | - |
Other Long-Term Assets | 3.6 | 12.17 | 53.1 | 173.64 | 9.39 |
Total Assets | 1,040 | 1,050 | 1,167 | 1,070 | 725.9 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | 31.21 | 46.9 | 36.49 | 6.31 | 4.17 |
Short-Term Debt | - | - | 7 | - | - |
Current Portion of Long-Term Debt | 37.01 | 1.82 | - | - | - |
Current Portion of Leases | 1.6 | - | 0.13 | - | - |
Current Income Taxes Payable | 0.26 | 0.15 | 0.22 | 0.11 | 0.08 |
Current Unearned Revenue | 1.5 | - | - | 9.4 | 8.64 |
Other Current Liabilities | 46.89 | 49.98 | 52.48 | 78.3 | 10.55 |
Total Current Liabilities | 118.47 | 98.86 | 96.31 | 94.11 | 23.42 |
Long-Term Debt | 222.61 | 53.09 | - | - | 1,238 |
Long-Term Leases | 11.78 | 12.62 | 12.09 | 11.22 | 10.58 |
Long-Term Unearned Revenue | 26.62 | 32.3 | 37.67 | 27.37 | 38.9 |
Total Liabilities | 379.47 | 196.87 | 146.07 | 132.7 | 1,310 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 202.45 | 202.45 | 202.45 | 192.06 | 90.89 |
Additional Paid-In Capital | 2,622 | 2,622 | 2,448 | 2,200 | 74.21 |
Retained Earnings | -2,088 | -1,938 | -1,770 | -1,520 | -795.31 |
Treasury Stock | -75.42 | -32.31 | - | - | - |
Comprehensive Income & Other | - | - | 139.77 | 66.19 | 45.68 |
Shareholders' Equity | 660.12 | 853.59 | 1,021 | 937.47 | -584.53 |
Total Liabilities & Equity | 1,040 | 1,050 | 1,167 | 1,070 | 725.9 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 273 | 67.53 | 19.22 | 11.22 | 1,248 |
Net Cash (Debt) | 146.47 | 386.15 | 589.11 | 570.42 | -683.7 |
Net Cash Growth | -62.07% | -34.45% | 3.28% | - | - |
Net Cash Per Share | 0.73 | 1.91 | 2.96 | 3.92 | -7.54 |
Filing Date Shares Outstanding | 198.91 | 200.99 | 202.45 | 192.06 | 90.73 |
Total Common Shares Outstanding | 198.91 | 200.99 | 202.45 | 192.06 | 90.73 |
Working Capital | 320.04 | 374.02 | 524.66 | 506.89 | 550.87 |
Book Value Per Share | 3.32 | 4.25 | 5.04 | 4.88 | -6.44 |
Tangible Book Value | 651.93 | 845.26 | 1,017 | 934.03 | -584.53 |
Tangible Book Value Per Share | 3.28 | 4.21 | 5.02 | 4.86 | -6.44 |
Machinery | 98.22 | 84.25 | 69.69 | 66.42 | 18.53 |
Construction In Progress | 62.71 | 184.24 | 113.92 | 152.81 | 60.15 |
Leasehold Improvements | 24.95 | 24.1 | 22.85 | 21.8 | 3.55 |